Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment

  • Pikalov, A
  • Tsai, J
  • Mao, Y
  • Cucchiaro, J
  • Loebel, A

  • aClinical Development and Medical Affairs, Sunovion Pharmaceuticals Inc., Fort Lee, USA, bMedical Affairs, Sunovion Pharmaceuticals Inc., Marlborough, USA, cClinical Development, Sunovion Pharmaceuticals Inc., Fort Lee, USA

Bipolar Disorders 17:p 88-89, June 2015.
Copyright © 2015 John Wiley & Sons, Ltd
View full text|Download PDF